Authors: Gori, S Mosconi, AM Tabilio, A Falzetti, F Aristei, C Basurto, C Cherubini, R Latini, P Martelli, MF Tonato, M Colozza, M

Citation: S. Gori et al., Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients, TUMORI, 87(3), 2001, pp. 138-141

Authors: Crino, L Mosconi, AM Calandri, C Corgna, E Porrozzi, S Chiara, S Nobili, MT Tonato, M

Citation: L. Crino et al., Gemcitabine in advanced pancreatic cancer - A phase II trial, AM J CL ONC, 24(3), 2001, pp. 296-298

Authors: Rinaldi, M Crino, L Scagliotti, GV Mosconi, AM De Marinis, F Gridelli, C Selvaggi, G Della Giulia, M Darwish, S Porrozzi, S Novello, S Cipri, A Bartolucci, R Calandri, C Tonato, M

Citation: M. Rinaldi et al., A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: A phase II randomizedtrial, ANN ONCOL, 11(10), 2000, pp. 1295-1300

Authors: Aristei, C Marsella, AR Chionne, F Panizza, BM Marafioti, L Mosconi, AM Cherubini, R Colozza, M

Citation: C. Aristei et al., Regional node failure in patients with four or more positive lymph nodes submitted to conservative surgery followed by radiotherapy to the breast, AM J CL ONC, 23(3), 2000, pp. 217-221

Authors: Crino, L Mosconi, AM Scagliotti, G Selvaggi, G Novello, S Rinaldi, M Della Giulia, M Gridelli, C Rossi, A Calandri, C De Marinis, F Noseda, M Tonato, M

Citation: L. Crino et al., Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial, J CL ONCOL, 17(7), 1999, pp. 2081-2085